Hikma Pharmaceuticals Plc (HKMPF)
17.30
0.00 (0.00%)
USD |
OTCM |
Apr 01, 16:00
Hikma Pharmaceuticals Market Cap : 3.754B for March 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 5.301M |
| Biodexa Pharmaceuticals Plc | 0.8751M |
| Oxford Biomedica Plc | 849.73M |
| NuCana Plc | 7.050M |
Market Cap Related Metrics
| PE Ratio | 9.528 |
| PS Ratio | 1.143 |
| PEG Ratio | 0.0848 |
| Price to Free Cash Flow | 91.12 |
| Price | 17.30 |
| Earnings Yield | 10.49% |
| PEGY Ratio | 0.0848 |
| Operating PE Ratio | 6.737 |
| Normalized PE Ratio | 10.31 |